Omega-3: validated benefits for cardiac, cognitive and inflammatory health

Omega-3s are essential fatty acids that play a key role in preventing cardiovascular disease, modulating inflammation, and maintaining healthy brain function. Their effectiveness is supported by robust clinical studies and recognized by health authorities such as the ANSM and the EMA . Focus on the scientifically proven benefits of omega-3s for your health.

Validated cardiovascular protection

Omega-3s, particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), contribute to the reduction of triglycerides, stabilization of heart rate and reduction of the risk of major cardiovascular events [1] [2].

The European Medicines Agency (EMA) recognizes the use of omega-3 at therapeutic doses in secondary prevention after a myocardial infarction [1].

Support for the brain and memory

DHA is a major constituent of neuronal membranes. Supplementation improves cognitive functions, particularly in the elderly or in cases of mild memory disorders [3].

Clinical trials show a correlation between sufficient omega-3 intake and a reduction in cognitive decline [4].

Reduction of inflammation

Omega-3s have an anti-inflammatory action through their transformation into resolvins and protectins, molecules which slow down inflammatory mechanisms [5].

They are useful in inflammatory joint disorders (rheumatoid arthritis, early osteoarthritis) [6].

Recommended food sources

• Oily fish: salmon, mackerel, sardines
• Linseed oil, rapeseed oil
• Nuts, chia seeds

Supplementation: when and how?

In case of deficiency or specific therapeutic objectives (cholesterol, memory, inflammation), supplementation is recommended.

• Standard dose: 250 to 1000 mg/day of EPA + DHA
• Form: Purified fish oil, softgels or reconstituted triglycerides
• Take with food for better absorption

Products available on Pharma+ France

We offer highly concentrated omega-3s, certified free of heavy metals, suitable for daily or therapeutic needs.

• Purified marine-sourced omega-3 (EPA/DHA)
• Strengthened formulas for the heart, joints or memory
• Suitable formats: 60, 90 or 120 capsules

Official references

1. EMA – Assessment report for Omega-3 acid ethyl esters , European Medicines Agency, 2021.
2. VIDAL – Omacor® Therapeutic Data Sheet (Omega-3-acid ethyl-esters 90), last updated 2023.
3. Yurko-Mauro K et al. *Cognitive benefits of docosahexaenoic acid (DHA)*, J Nutr. 2010.
4. Swanson D et al. *Omega-3 fatty acids EPA and DHA: health benefits throughout life*, Adv Nutr. 2012.
5. Calder PC. *Omega-3 fatty acids and inflammatory processes: from molecules to man*, Biochem Soc Trans. 2017.
6. ANSM – Recommendations on food supplements containing omega-3, 2020.

Legal notices
This product is marketed by the parapharmacy “Pharma+ France” belonging to the company Groupe Nobélis SASU, a company registered with the Paris Trade and Companies Register under number 941 724 544, whose head office is located at 1 RUE DE STOCKHOLM, 75008 PARIS. Groupe Nobélis SASU is not the manufacturer of this product, unless otherwise stated on the packaging or technical data sheet.

The information in this article is provided for informational purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the French Consumer Code.

They cannot in any case constitute a medical prescription nor replace the consultation of a qualified health professional. Any use of the product must comply with the instructions, the recommended dosage, and the precautions for use.

In accordance with Article L. 5122-15 of the Public Health Code, Groupe Nobélis declines all responsibility in the event of misuse, self-medication or non-compliance with official recommendations.

Photographs, descriptions, and technical information are non-contractual and are subject to change at any time. The user is encouraged to regularly check for updates or contact a healthcare professional for any treatment-related questions.